Clinical Trial: A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07658482) titled 'A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers' on June 10.

Brief Summary: This is a phase 1, single dose, randomized, open-label, parallel-group study to evaluate the pharmacokinetics (PK), safety, tolerability and immunogenicity of ZL-1503 and to explore its PD biomarkers following a single subcutaneous (SC) or intravenous (IV) administration in healthy volunteers.

Study Start Date: Sept. 03, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: ZL-1503

Healthy volunteers will receive a single intravenous dose of ZL-1503.

DRUG: ZL-1503

Hea...